New Orleans, Louisiana

Bethune University of Medical Sciences – Changchun, China

I like every aspect of pathology.

Swimming, biking, hiking, reading books.


Interactions between MUC1 and p120 catenin regulate dynamic features of cell adhesion, motility and metastasis. Liu X, Yi C, Wen Y, Radhakrishnan P, Tremayne JR, Dao T, Johnson KR, Hollingsworth MA. Cancer Res. 2013 Dec 30. [Epub ahead of print]

The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF. Behrens ME, Grandgenett PM, Bailey JM, Singh PK, Yi CH, Yu F, Hollingsworth MA. Oncogene. 2010 Oct 21;29(42):5667-77. doi: 10.1038/onc.2010.327. Epub 2010 Aug 9.

Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathways. Hoffman AE, Zheng T, Ba Y, Stevens RG, Yi CH, Leaderer D, Zhu Y. BMC Cancer. 2010 Mar 24;10:110. doi: 10.1186/1471-2407-10-110.

The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling. Hoffman AE, Zheng T, Yi CH, Stevens RG, Ba Y, Zhang Y, Leaderer D, Holford T, Hansen J, Zhu Y. Cancer Prev Res (Phila). 2010 Apr;3(4):539-48. doi: 10.1158/1940-6207.CAPR-09-0127. Epub 2010 Mar 16.

CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Hoffman AE, Yi CH, Zheng T, Stevens RG, Leaderer D, Zhang Y, Holford TR, Hansen J, Paulson J, Zhu Y. Cancer Res. 2010 Feb 15;70(4):1459-68. doi: 10.1158/0008-5472.CAN-09-3798. Epub 2010 Feb 2.

The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer. Yi C, Mu L, de la Longrais IA, Sochirca O, Arisio R, Yu H, Hoffman AE, Zhu Y, Katsaro D. Breast Cancer Res Treat. 2010 Apr;120(3):663-9. doi: 10.1007/s10549-009-0484-0. Epub

microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T, Zhu Y. Cancer Res. 2009 Jul 15;69(14):5970-7. doi: 10.1158/0008-5472.CAN-09-0236. Epub 2009 Jun 30. Erratum in: Cancer Res. 2009 Aug 15;69(16):6758.

Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis. Yi CH, Zheng T, Leaderer D, Hoffman A, Zhu Y. Cancer Lett. 2009 Nov 1;284(2):149-56. doi: 10.1016/j.canlet.2009.04.017. Epub 2009 May 19.

Clock-cancer connection in non-Hodgkin’s lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Hoffman AE, Zheng T, Stevens RG, Ba Y, Zhang Y, Leaderer D, Yi C, Holford TR, Zhu Y. Cancer Res. 2009 Apr 15;69(8):3605-13. doi: 10.1158/0008-5472.CAN-08-4572. Epub 2009 Mar 24.

Loss of fibulin-2 expression is associated with breast cancer progression. Yi CH, Smith DJ, West WW, Hollingsworth MA. Am J Pathol. 2007 May;170(5):1535-45.

Journal of the National Cancer Institute. Manuscript No. JNCI-11-0785